Thank you for participating in this brief pre-activity survey.
Once you have completed the survey, you will be directed to the full supplement where you can read all of the articles and take the posttest for CE accreditation.

In an effort to better determine the overall impact of continuing education activities, the Postgraduate Institute for Medicine (PIM) is conducting measurements of educational effectiveness. Listed below are several demographic questions to better identify who is in the audience and several statements for which we would like you to rate your level of agreement/disagreement. All information obtained in this process will be used and reported in aggregate only, without individual attribution. Thank you for your participation.

 
 
Please answer the questions that follow. (please choose one.)
To what extent do you agree with the following statements?
(please circle the appropriate number on the scale.)
 
MD/DO Pharmacist NP/RNCase Manager Other
 
What best describes your primary role?
 
Pharmacy Director Pharmacist Medical Director Clinical
LTC Pharmacist Pharmacy Consultant PBM Pharmacist
Integrated Health System Pharmacist Management Disease Management Pharmacist Utilization/Claims
Quality Director or Associate Policy Disease Management Physician CMS/Government
Employer Administration Other Pharmacist Other Clinician
Case Manager Pharmacy Student Other
 
Is your primary responsibility in a managed care health setting?
 
Yes No
 
How many years have you been in your area of responsibility?
 
< 55 - 1011 - 20 > 20
 
1.When prescribing ADHD medications, current ADHD treatment guidelines recommend extended-release formulations of stimulants over immediate-release preparations.
Strongly disagree 1 2 3 4 5 6 Strongly agree
 
2.There are validated assessment tools to aid in the diagnosis of ADHD for adults presenting with symptoms in accordance with DSM-IV criteria.
Strongly disagree 1 2 3 4 5 6 Strongly agree
 
3. For patients with ADHD and no predominant psychiatric comorbidities, stimulant pharmacotherapy is the most clinically desirable and cost-effective approach to care.
Strongly disagree 1 2 3 4 5 6 Strongly agree
 

4. Appropriate pharmacotherapy in children with ADHD is associated with reduced emergency department use and medical costs.
Strongly disagree 1 2 3 4 5 6 Strongly agree
 
5. During the titration phase of medication initiation in children and adolescents with ADHD, observations of the patient's behavior should be sought from multiple sources in evaluating the effect of the medication.
Strongly disagree 1 2 3 4 5 6 Strongly agree
 

6. The use of pharmacy database monitoring assists in improving patient outcomes by tracking medication adherence in adult ADHD patients.

Strongly disagree 1 2 3 4 5 6 Strongly agree